Dr Emily Rosenich (she/her) is a Postdoctoral Research Fellow in Neuropsychology within the Turner Institute for Brain and Mental Health in the School of Psychological Sciences. Her research investigates vascular, lifestyle and genetic contributors to cognitive decline and dementia. Emily has a particular research focus on investigating the synergistic effects of vascular risk factors and APOE E4 carriage on cognitive impairment and decline across the lifespan. 

A large portion of Emily's work also involves the management, facilitation and analysis of data within a large, NHMRC-funded randomised controlled trial (BetterBrains) to delay cognitive decline in middle-aged adults with a family history of dementia.

Emily completed her PhD in clinical neuroscience and rehabilitation at the University of South Australia in late 2020, where her research aimed to disentangle the relationship between cognitive reserve and recovery following stroke. Her research also focused on understanding the interaction between cognitive reserve and functional connectivity on motor recovery throughout the first 3-months post-stroke.

Emily has strong research interests in the areas of cognitive and vascular disorders, non-modifiable (e.g. genetic) and modifiable (i.e. vascular, lifestyle) moderators of neurodegenerative disease progression and cognitive impairment/decline, psychometrics and statistical modelling, and the design and implementation of digital (remote) interventions to promote modifiable lifestyle changes.

In addition to her scientific work, Emily is a strong advocate for quality science, science communication and increasing community engagement with scientific concepts and research. She frequently initiates community events aimed at increasing the dementia literacy of the general public. She is also involved in initatives encouraging Australian youth, particularly young women and girls, to become involved and interested in neuroscience and other science-based careers.